Mediterranean Diet Linked to Slower Cognitive Decline in Older Adults
UK Aims to Speed Up Clinical Trials with Faster Assessments and Agile Regulation
Avocado Consumption Linked to Improved Cholesterol Profiles
Metabolomic Signature Helps Predict Type 2 Diabetes Risk
Small Daily Movement Could Save Lives and Reduce Early Deaths
Scientists Develop Lung-on-a-Chip Model to Study Tuberculosis
Preserving Muscle and Bone After Hormonal Change
Green Tea Compounds Linked to Improved Cellular Ageing Markers
WHO Highlights Physical Activitys Role in Preventing Chronic Disease
November 28, 2024
Doromongy Faces Backlash for Allegedly Selling Ozempic Injections
Mongy Semakaleng Mathobela, founder of Doro Mongy Empire, is under fire for reportedly selling Ozempic injections.
Known for her diverse product range, including skincare and gym sets, Mathobela allegedly added the diabetes drug—commonly misused for weight loss—to her offerings. The South African Health Products Regulatory Authority (SAHPRA) has warned against unauthorized Ozempic sales, citing potential health risks and its limited availability for diabetic patients.
Controversial blogger Musa Khawula claimed the injections were priced at R23,000, sparking legal and ethical concerns among social media users.
Copyright © 2025 Dotcom Africa. All Rights Reserved. Advertising Terms | Terms of Use | Contact | Advertise with us | About Us